Therapy News and Research

RSS

New target for cancer therapy identified by Australian researchers

A new target for cancer therapy has been identified by Monash University scientists investigating the cell signalling pathways that turn on a gene involved in cancer development.

21 Sep 2006

Leptin could combat type 2 diabetes

University of Florida researchers have discovered the appetite-controlling hormone leptin could also combat type 2 diabetes, a disease that has become a growing problem in the United States as more Americans pack on extra pounds.

21 Sep 2006

How the brain resolves emotional conflict

Daily life requires that people cope with distracting emotions--from the basketball player who must make a crucial shot amidst a screaming crowd, to a salesman under pressure delivering an important pitch to a client.

21 Sep 2006

WHO backs health sector response to HIV pandemic

The World Health Organization Western Pacific Region, in collaboration with international partner agencies, is seeking to scale up HIV/AIDS prevention and control activities in line with the goal of universal access for HIV/AIDS treatment throughout Asia and the Pacific by 2010.

21 Sep 2006

Carbon monoxide shown to reverse symptoms of pulmonary hypertension

In a medical case of Jekyll and Hyde, carbon monoxide - the highly toxic gas emitted from auto exhausts and faulty heating systems - has proven effective in treating the symptoms of pulmonary arterial hypertension (PAH), an extremely debilitating condition that typically leads to right heart failure and eventual death.

20 Sep 2006

GSK seeks regulatory approval in U.S., Europe for Tykerb

GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of this year, Reuters reports.

20 Sep 2006

Use of unapproved drugs in the U.S.

USA Today on Monday looked at the use of unapproved drugs in the U.S., including some that are used to treat menopause symptoms (Rubin, USA Today, 9/18).

20 Sep 2006

BlueCross BlueShield of Illinois adds coverage for MammoSite

BlueCross BlueShield of Illinois after meeting with experts last week has decided to cover the partial-breast radiation therapy known as MammoSite for patients with early stage breast cancer, officials for the insurer said, the Chicago Sun-Times reports.

20 Sep 2006

Jury dismisses lawsuit against Wyeth in first Pempro case

A jury in a U.S. District Court in Little Rock, Ark., on Friday dismissed negligence charges in the first of about 5,000 lawsuits filed over Prempro, a combination hormone replacement therapy manufactured by Wyeth, and found the drug's design was not defective, Reuters reports.

20 Sep 2006

USAID issues $15M grant to Ugandan religious coalition

USAID through the President's Emergency Plan for AIDS Relief issued a $15 million three-year grant to the Inter-Religious Council of Uganda -- a coalition of five religious groups that promote faith-based strategies to fight the HIV/AIDS epidemic, AFP/Today Online reports.

20 Sep 2006

Aromatase inhibitors improve survival of advanced breast cancer patients compared to tamoxifen

Aromatase inhibitors improve the survival of advanced breast cancer patients compared to standard hormone therapies like tamoxifen, a researchers report in the September 20 issue of the Journal of the National Cancer Institute.

19 Sep 2006

Nicotinamide may help people with multiple sclerosis

Researchers have found a possible way to protect people with multiple sclerosis (MS) from severe long-term disability: increase nervous-system levels of a vital compound, called nicotinamide adenine dinucleotide (NAD), by giving its chemical precursor - nicotinamide, a form of vitamin B3.

19 Sep 2006

Curcumin useful in the fight against colorectal cancer

Looking for a cancer cure? Try the spice rack. In the last few years, that tactic has proved productive for researchers investigating turmeric, a curry spice used for centuries in Indian traditional medicine.

19 Sep 2006

Cisplatin nanoliposomes for cancer therapy

Cisplatin is one of the most powerful and effective drugs for treating a wide variety of cancers, but many tumors develop resistance to this drug, ultimately limiting its benefits for cancer patients.

19 Sep 2006

Blue Cross Blue Shield of Illinois coverage policy for partial-breast radiation therapy to be reviewed

Blue Cross Blue Shield of Illinois' policy that it does not cover partial-breast radiation therapy was scheduled to be reviewed last Wednesday in Dallas during a three-day meeting of Health Care Service Corporation officials, the Chicago Sun-Times reports.

18 Sep 2006

Acupuncture for low back pain provides long-term benefit

Low back pain is one of the most common medical complaints and affects millions of people, and according to researchers in the UK the ancient Chinese treatment acupuncture can help sufferers.

18 Sep 2006

Uroplasty receives FDA approvable letter for treatment of female stress urinary incontinence

Uroplasty, Inc. has announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) relating to its pre-market approval (PMA) application for Macroplastique Implants for the treatment of female stress urinary incontinence (SUI).

14 Sep 2006